Modified enzyme immunoassay for detecting Neisseria gonorrhoeae antigens.
AUTOR(ES)
Papasian, C J
RESUMO
A commercial modification of an enzyme immunoassay (EIA) (Gonozyme; Abbott Laboratories, North Chicago, Ill.) for detection of Neisseria gonorrhoeae antigens was compared with conventional culturing. Specimens from males and females were collected at a sexually transmitted disease clinic; additional female specimens were collected at an obstetrics and gynecology clinic. EIA sensitivity and specificity for males were 100 and 98.6%, respectively (68 negative, 34 positive, 1 false-positive, and 0 false-negative). EIA sensitivity and specificity for female sexually transmitted disease clinic patients were 74.4 and 95.7%, respectively (66 negative, 29 positive, 3 false-positive, and 10 false-negative) EIA sensitivity and specificity for obstetrics and gynecology clinic patients were 100 and 99.2%, respectively (6 positive, 119 negative, 1 false-positive, and 0 false-negative). In female patients from whom multiple swab specimens were collected, the sequence of specimen collection and subsequent EIA analysis affected sensitivity.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=271401Documentos Relacionados
- Validity of an enzyme immunoassay for detection of Neisseria gonorrhoeae antigens.
- Detection of Neisseria gonorrhoeae antigen by a solid-phase enzyme immunoassay.
- New enzyme immunoassay for detecting cryptococcal antigen.
- Probing the surface of Neisseria gonorrhoeae: simultaneous localization of protein I and H.8 antigens.
- Comparison of the PREMIER cryptococcal antigen enzyme immunoassay and the latex agglutination assay for detection of cryptococcal antigens.
